Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-16T22:34:55.747Z Has data issue: false hasContentIssue false

Validation of oral-nasal specimen collection for influenza and respiratory syncytial virus detection

Published online by Cambridge University Press:  23 April 2025

Matthew Young
Affiliation:
Department of Medicine, Michael Garron Hospital, University of Toronto, Toronto, ON, Canada
Yuri Suico
Affiliation:
Department of Medicine, Michael Garron Hospital, University of Toronto, Toronto, ON, Canada
Omid Kyle Vojdani
Affiliation:
Department of Medicine, Michael Garron Hospital, University of Toronto, Toronto, ON, Canada
Janine McCready
Affiliation:
Department of Medicine, Michael Garron Hospital, University of Toronto, Toronto, ON, Canada
Kevin Katz
Affiliation:
Department of Laboratory Medicine, University of Toronto, Toronto, ON, CanadaShared Hospital Laboratory, Toronto, ON, CanadaNorth York General Hospital, Toronto, ON, Canada
Scarlett Pourmatin
Affiliation:
Shared Hospital Laboratory, Toronto, ON, Canada
Manija Rahimi
Affiliation:
Shared Hospital Laboratory, Toronto, ON, Canada
Christie Vermeiren
Affiliation:
Shared Hospital Laboratory, Toronto, ON, Canada
Jeff Powis
Affiliation:
Department of Medicine, Michael Garron Hospital, University of Toronto, Toronto, ON, Canada
Christopher Kandel*
Affiliation:
Department of Medicine, Michael Garron Hospital, University of Toronto, Toronto, ON, CanadaFaculty of Medicine, University of Toronto, Toronto, ON, Canada
*
Corresponding author: Christopher Kandel; Email: christopher.kandel@tehn.ca

Abstract

Objective:

Respiratory virus testing is routinely performed and ways to obtain specimens aside from a nasopharyngeal swab are needed for pandemic preparedness. The main objective is to validate a self-collected oral-nasal swab for the detection of Influenza and respiratory syncytial virus (RSV).

Design:

Diagnostic test validation of a self-collected oral nasal swab as compared to a provider-collected nasopharyngeal swab.

Setting:

Emergency Department at Michael Garron Hospital.

Participants:

Consecutive individuals who presented to the Emergency Department with a suspected viral upper respiratory tract infection were included if they self-collected an oral-nasal swab. Individuals testing positive for Influenza or RSV along with randomly selected participants who tested negative were eligible for inclusion.

Interventions:

All participants had the paired oral-nasal swab tested using a multiplex respiratory virus polymerase chain reaction for the three respiratory pathogens and compared to the nasopharyngeal swab.

Results:

48 individuals tested positive for Influenza, severe acute respiratory coronavirus virus 2 (SARS-CoV-2) or RSV along with 80 who tested negative. 110 were symptomatic with the median time from symptom onset to testing of 1 day (interquartile range 2–5 days). Using the clinical nasopharyngeal swab as the reference standard, the sensitivity was 0.75 (95% CI, 0.43–0.95) and specificity was 0.99 (95% CI, 0.93–1.00) for RSV, sensitivity is 0.67 (95% CI, 0.49–0.81) and specificity is 0.96 (95% CI, 0.89–0.99) for Influenza.

Conclusions:

Multiplex testing with a self-collected oral-nasal swab for Influenza and RSV is not an acceptable substitute for a healthcare provider collected nasopharyngeal swab primarily due to suboptimal Influenza test characteristics.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Performance characteristics of respiratory syncytial virus and influenza detection in paired nasopharyngeal swab and oral-nasal swab specimens from individuals presenting to the emergency department

Figure 1

Figure 1.Cycle threshold values for the healthcare provider collected clinical nasopharyngeal swab and the paired self-collected combined oral-nasal swab for respiratory syncytial virus (A), influenza A (B) and influenza B (C). One nasopharyngeal swab for Influenza A did not have a cycle threshold available.